Cytokinetics Inc
CYTK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061983
In the last 90 days, Cytokinetics Inc insiders filed 0 open-market purchases and 19 sales; 482 institutions reported holding it in 13F filings for Q2 2026, worth $13.7B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Cytokinetics Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- −2 vs. Q1 2021
- Shares held
- 75.8M
- +991.2K (+1.3%) vs. Q1 2021
- Total value
- $1.50B
- −$238.0M (−13.7%) vs. Q1 2021
- New holders
- 20
- 69 more added
- Sold out
- 22
- 66 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYTK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 482 | $13.7B |
| Q1 2026 | 441 | $9.63B |
| Q4 2025 | 431 | $8.87B |
| Q3 2025 | 381 | $7.75B |
| Q2 2025 | 312 | $4.55B |
| Q1 2025 | 356 | $5.48B |
| Q4 2024 | 347 | $6.18B |
| Q3 2024 | 348 | $7.20B |
| Q2 2024 | 344 | $7.34B |
| Q1 2024 | 390 | $8.26B |
| Q4 2023 | 347 | $9.54B |
| Q3 2023 | 251 | $3.22B |
| Q2 2023 | 253 | $3.55B |
| Q1 2023 | 263 | $3.83B |
| Q4 2022 | 278 | $4.88B |
| Q3 2022 | 276 | $5.08B |
| Q2 2022 | 263 | $4.16B |
| Q1 2022 | 240 | $3.52B |
| Q4 2021 | 250 | $4.16B |
| Q3 2021 | 211 | $3.22B |
| Q2 2021 | 191 | $1.50B |
| Q1 2021 | 193 | $1.74B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Cytokinetics Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Victory Capital Management Inc | 0 | $0 | 0.00% | −9,933−100.0% | Sold out |
| Veracity Capital LLC | 0 | $0 | 0.00% | −9,715−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −9,410−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −9,089−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −9,009−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −3,417−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −410−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −419−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −273−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| BDO Wealth Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |